Moreover, the proportion of FTH1 and GPX4 high expression in imatinib‐resistant GIST samples is greater than that in imatinib‐sensitive samples, confirmed by the quantification of IHC staining (Figure 1G,H). This evidence concerns the gene FTH1 and gastrointestinal stromal tumor.